Efficiency and Outcomes of Stress-Only Anger and D-SPECT Stress-Only SPECT MPI

December 20, 2013 updated by: Aspire Foundation

Rapid-Acquisition Low-Dosimetry Tc-99m Stress-Only Myocardial Perfusion SPECT on the Spectrum Dynamics System: Comparison of Efficiency and Outcomes With Stress-Only Anger SPECT

The purpose of this study is to compare clinical efficiency and patient outcomes using ultra low-dose stress only Tc-99m and solid-state SPECT versus traditional Anger SPECT.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Missouri
      • Kansas City, Missouri, United States, 64111
        • Saint Luke's Cardiovascular Imaging Center
      • Kansas City, Missouri, United States, 64154
        • Saint Luke's North Cardiovascular Imaging Center
      • Lee's Summit, Missouri, United States, 64086
        • Saint Luke's East Cardiovascular Imaging Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 90 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Consecutive patients referred for clinically-indicated myocardial perfusion SPECT

Description

Inclusion Criteria:

  • BMI < 35 kg/m2
  • LVEF > 40%
  • Exercise stress
  • Elective out-patients
  • No known CAD (>50%) by catheterization
  • No history of prior myocardial infarction

Exclusion Criteria:

  • LBBB
  • Pacemaker
  • Atrial Fibrillation
  • Frequent PAC's or PVC's
  • Inability to achieve at least 6 minutes

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Stress Only SPECT MPI with Anger Camera
Patients undergoing clinically-indicated stress-only sestamibi studies who are imaged on the traditional Anger camera
Stress Only SPECT MPI with SD Camera
Patients undergoing clinically-indicated stress-only sestamibi studies who are imaged on the Spectrum Dynamics camera system.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Diagnostic Failure
Time Frame: 30 days
Diagnostic failure is defined by a composite of need for additional downstream testing (anger SPECT, MPI PET, stress echocardiography or coronary CT angiography) within 30 days or a coronary angiogram with no stenoses greater than or equal to 50% severity using quantitative coronary angiography.
30 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Necessity to proceed to a rest image
Time Frame: 30 days
The first of 4 secondary end-points is the need to proceed to a rest image.
30 days
Necessity for additional downstream testing
Time Frame: 30 days
The second of four secondary endpoints the need for additional downstream testing within 30 days to address the same clincial reason for the innitial referral for stress-onoly imaging, in the absence of any changes in clincial status between tests.
30 days
Coronary Angiography
Time Frame: 60 to 90 days
The third of four secondary end-points is the occurrence of coronary angiography with no stenoses greater than or equal to 50% severity using quantitative coronary angiography.
60 to 90 days
Determine optimal performance of the Spectrum Dynamics camera system for stress only imaging
Time Frame: 60 to 90 days
The fourth of four secondary endpoints is to determine optimal performance of the Spectrum Dynamics camera system for stress only imaging: upright imaging alone, supine imaging alone, or both in terms of primary and secondary endpoints
60 to 90 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: Timothy M Bateman, MD, Aspire Foundation

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2010

Primary Completion (Actual)

January 1, 2012

Study Completion (Actual)

January 1, 2012

Study Registration Dates

First Submitted

June 14, 2011

First Submitted That Met QC Criteria

June 14, 2011

First Posted (Estimate)

June 15, 2011

Study Record Updates

Last Update Posted (Estimate)

December 23, 2013

Last Update Submitted That Met QC Criteria

December 20, 2013

Last Verified

December 1, 2013

More Information

Terms related to this study

Other Study ID Numbers

  • D-Spect Stress Only

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.